ATLyphe raises €140K Seed round
1 October 2023· Zürich, Switzerland· health, biotech, immunotherapy, precision_medicine, drug_discovery, b2b
The funds will be used for Business Development and IP-related experiments.
Investors
LeadVenture Kick
About ATLyphe
Stage
Seed
Headquarters
Zürich, Switzerland
Founded
2023
Team Size
1–5
Sectors
healthbiotechimmunotherapyprecision_medicinedrug_discoveryb2b